The RxNorm value sets for the 2014 measure republication were updated for the EP measures on May 30, 2014 and will reflect the current RxNorm code system version as of January 2014. In general, CMS and ONC accept remapping of clinically similar or identical codes to the codes present in the Meaningful Use EHR Incentive Program eCQMs. If an audit were performed, system or EHR data should demonstrate that codes remapped to published value set content are clinically appropriate. It is acceptable to use terminology services or clinical expertise to provide that mapping provided it would be considered clinically appropriate. Over time, CMS and ONC, in concert with NLM, hope to provide more frequently updated content and additional guidance in remapping value sets, but for Stage 2 of the Meaningful Use program, the statute allows value set updates no more frequently than on an annual basis. The only change to value sets for this measure since the June 2013 update was the removal of one code from the "Face-to-Face Interaction" value set which applies to several measures. We did not remove the "Dapsone and pyrithimine" value set from the list as the code is still active within RxNorm and in alignment with the latest guidance, even if not prescribed. When the issue first arose, we agreed to investigate so we could update as appropriate in the June 2014 update. However, our assessment is as described above, ie, this value set is still included.